Thyroid-stimulating hormone induces interleukin-6 release from human adipocytes through activation of the nuclear factor-κB pathway

Endocrinology

Volumn 149, Issue 6, 2008, Pages 3062-3066

  Antunes, Tayze T ^a   Gagnon, AnneMarie ^a   Langille, Melanie L ^a   Sorisky, Alexander ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; SN 50; THYROTROPIN;

ADIPOCYTE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ADIPOCYTES; ANIMALS; CELL CULTURE TECHNIQUES; CHO CELLS; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INTERLEUKIN-6; KINETICS; NF-KAPPA B; POLYMERASE CHAIN REACTION; THYROTROPIN;

EID: 44249095564     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1588     Document Type: Article

References (22)

1. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW 1997 Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor α, in vivo. J Clin Endocrinol Metab 82:4196-4200
2. Lobbes MBI, Lutgens E, Heeneman S, Cleutjens KBJM, Kooi ME, van Engelshoven JMA, Daemen MJAP, Nelemans PJ 2006 Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin 6, and oxidized low density lipoprotein with respect to coronary and cerebral vascular disease. Atherosclerosis 187:18-25
3. Lee KWJ, Hill JS, Walley KR, Frohlich JJ 2006 Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angioplasty cohort. Can Med Assoc J 174:461-466
4. Fisman EZ, Benderly M, Esper RJ, Behar S, Boyko V, Adler Y, Tanne D, Matas Z, Tenenbaum A 2006 Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction. Am J Cardiol 98:14-18
5. Stork S, Feelders RA, van den Beld AW, Steyerberg EW, Savelkoul HFJ, Lamberts SWJ, Grobbee DE, Bots ML 2006 Prediction of mortality risk in the elderly. Am J Med 119:519-525
6. Rodondi N, Aujesky D, Vittinghoff E, Cornuz J, Bauer DC 2006 Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med 119:541-551
7. Dardano A, Ghiadoni L, Plantinga Y, Caraccio N, Bemi A, Duranti E, Taddei S, Ferrannini E, Salvetti A, Monzani F 2006 Recombinant human TSH reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma. J Clin Endocrinol Metab 91:4175-4178
8. Antunes TT, Gagnon A, Chen B, Pacini F, Smith TJ, Sorisky A 2006 Interleukin-6 release from human abdominal adipose cells is regulated by thyroidstimulating hormone: effect of adipocyte differentiation and anatomic depot. Am J Physiol: Endocrinol Metab 290:E1140-E1144
9. Antunes TT, Gagnon A, Bell A, Sorisky A 2005 Thyroid-stimulating hormone stimulates interleukin-6 release from 3T3-L1 adipocytes through a cAMP protein kinase A pathway. Obes Res 13:2066-2071
10. Chung S, Lapoint K, Martinez K, Kennedy A, Boysen Sandberg M, Mcintosh MK 2006 Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147:5340-5351
11. Shoelson SE, Lee J, Goldfine AB 2006 Inflammation and insulin resistance. J Clin Invest 116:1793-1801
12. Van Sande J, Costa MJ, Massart C, Swillens S, Costagliola S, Orgiazzi J, Dumont JE 2003 Kinetics of thyrotropin-stimulating hormone (TSH) and thyroid-stimulating antibody binding and action on the TSH receptor in intact TSH receptor-expressing CHO cells. J Clin Endocrinol Metab 88:5366-5374
13. Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
14. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, Roger PP 2001 Regulation of thyroid cell proliferation by TSH and other factors. Endocr Rev 22:631-656
15. Davies TF, Marians R, Latif R 2002 The TSH receptor reveals itself. J Clin Invest 110:161-164
16. Van Sande J, Dequanter D, Lothaire P, Massart C, Dumont JE, Erneux C 2006 Thyrotropin stimulates the generation of inositol 1,4,5-trisphosphate in human thyroid cells. J Clin Endocrinol Metab 91:1099-1107
17. Cao X, Kambe F, Seo H 2005 Requirement of thyrotropin-dependent complex formation of protein kinase A catalytic subunit with inhibitor of B proteins for activation of p65 nuclear factor-B by tumor necrosis factor-α. Endocrinology 146:1999-2005
18. Ye RD 2001 Regulation of nuclear factor κB by G protein-coupled receptors. J Leuk Biol 70:839-848
19. Skurk T, Van Harmelan V, Hauner H 2004 Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-κB. Arterioscler Thromb Vasc Biol 24:1199-1203
20. Karin M 2006 Role for IKK2 in muscle: waste not, want not. J Clin Invest 116:2866-2868
21. Berg AH, Lin Y, Lisanti MP, Scherer PE 2004 Adipocyte differentiation induces dynamic changes in NF-κB expression and activity. Am J Physiol Endocrinol Metab 287:E1178-E1188
22. Hotamisligil GS 2006 Inflammation and metabolic disorders. Nature 444:860-867